Related Experiment Video
Updated: Jun 23, 2026

Laryngeal Mask Airway (LMA) Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway (SGA)
Published on: July 14, 2023
Nasal CPAP therapy for infants with congenital stridor
G Zwacka1, S Scholle, G Kemper
1Robert-Koch-Krankenhaus, Kinderklinik/Schlafmedizinisches Zentrum, 99510, Apolda.
Insights
Non-invasive continuous positive airway pressure (nCPAP) therapy effectively treats congenital inspiratory stridor in infants. This treatment alleviates symptoms, stabilizes oxygen saturation, and improves sleep, potentially avoiding invasive procedures.
Area of Science:
- Pediatric Pulmonology
- Neonatology
- Respiratory Medicine
Background:
- Congenital inspiratory stridor affects infants, necessitating accurate diagnosis and effective treatment.
- Laryngomalacia is a common cause of stridor, potentially leading to respiratory distress.
- Conventional treatments may involve invasive procedures like intubation or surgery.
Purpose of the Study:
- To evaluate the efficacy of non-invasive continuous positive airway pressure (nCPAP) therapy in infants with congenital inspiratory stridor.
- To assess the diagnostic methods including clinical examination, endoscopy, and polygraphy for stridor assessment.
- To determine the impact of nCPAP on clinical parameters and sleep quality in affected infants.
Main Methods:
- Ten infants aged 1–5 months with congenital inspiratory stridor were examined.
- Diagnostic assessments included clinical evaluation, endoscopy, and polygraphy based on stridor severity.
- nCPAP therapy was administered to assess its therapeutic effects.
Main Results:
- nCPAP therapy successfully treated infants as young as one month with laryngomalacia.
- Significant improvements observed: reduced thoracic recession, less funnel chest development, stabilized SpO2 (~95%), and diminished stridor.
- Normalized heart rate, improved sleep quality with reduced motility, and faster symptom resolution compared to untreated children.
Conclusions:
- nCPAP therapy is a highly effective non-invasive treatment for congenital inspiratory stridor in infants.
- This approach leads to significant clinical improvements and better sleep quality.
- nCPAP therapy can successfully avoid the need for intubation, tracheotomy, or laryngeal surgery.
Abstract:
Ten infants at ages from 1 to 5 months (1st and 2nd trimenon) suffering from congenital inspiratory stridor were examined, dependent on the respective severity of their stridorous phenomenons each, either clinically or/and endoscopically or/and polygraphically, for differentiation of the diagnoses and for assessment of their needs of nCPAP therapy.With the help of nCPAP it is possible to successfully treat even one-month-old babies who suffer from laryngomalacia. The therapy results in effective alleviation of the thorax recession, reduction of funnel chest development, stabilization of SaO2 around 95%, almost complete disappearing of the stridor through laryngeal functional stabilization and the normalization of the increased heart rate. Also to be emphasized is improvement of the sleep which is characterized by remarkably reduced motility. With nCPAP therapy the stridorous symptomatology is reduced within shorter time than even less severe phenomenons disappear in untreated children. By this therapeutic approach intubation, tracheotomy or laryngeal surgery can be avoided.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiopulmonary Resuscitation II: ACLS Airway Management
Suctioning the Nasopharyngeal Airway
Equipment Required
Respiratory Syncytial Virus Disease
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
